An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract.
Linezolid has been studied across 15 research domains including 🫘 Kidney, 😴 Sleep, 🧠 Focus & Attention, 🫁 Liver & Detox, 🌤️ Mood & Depression. The primary research focus is 🫘 Kidney with 7% of studies addressing this area.
The following compounds share molecular targets with Linezolid, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Linezolid is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.